Author: Himanshu Patni
12 August 2023
The Asia Pacific is home to a large patient population as the region consists of countries such as China, India, Japan, Malaysia, Indonesia, and others. The region has a high prevalence of cardiac disorders and related diseases. This has increased the demand for effective and advanced diagnostic systems, which are used for the early detection and diagnosis of these diseases. Moreover, Governments in the Asia Pacific region are increasing their healthcare expenditure to improve the quality of healthcare and address the growing burden of chronic diseases. This has led to increased investment in ophthalmic diagnosis and treatment, including the adoption of OCT devices. For instance, Central and State Governments’ budgeted expenditure on the health sector reached 2.1% of GDP in FY23 (BE) and 2.2 percent in FY22 (RE), against 1.6% in FY21.
Access sample report (including graphs, charts, and figures): https://univdatos.com/get-a-free-sample-form-php/?product_id=42330
Further, the Asia-Pacific Artificial Intelligence in Cardiology Market is expected to grow at a strong CAGR of 9% during the forecast period (2022-2030). The geriatric population in the region is becoming a major concern for healthcare facilities in dealing with the rising number of patients and hospitalization cases which results in increased pressure over hospital and clinic staff in dealing with the increasing number of patients is also an important reason for the market growth of AI in cardiology in Asia- Pacific.
Based on components, the market is segmented into hardware, software solutions, and services. The software segment is to grow with the highest CAGR in AI in the cardiology market. The rising adoption of AI-based software in the healthcare industry to manage patient heart records such as heart rates, ECG rates, and medication monitoring. This software enables practitioners the assessment of risk and helps medical professionals in the decision-making about treatment and its management.
Based on the application, the market is segmented into cardiac arrhythmias, stroke, cardiac heart disease, and others. The cardiac arrhythmias segment is expected to grow with a higher CAGR in the artificial intelligence in cardiology market during the forecast period. Arrhythmia is a condition where the heart beats irregularly, which can lead to serious health problems, including stroke and heart failure. The increasing prevalence of arrhythmia is an important reason for the market growth of the segment in artificial intelligence in the cardiology market. For instance, as per the Research Published in NCBI, the prevalence of atrial fibrillation is accounted for around 1% of the Indian population.
For a detailed analysis of Global Artificial Intelligence in the Cardiology Market browse through –https://univdatos.com/report/artificial-intelligence-in-cardiology-market/
Global Artificial Intelligence in Cardiology Market Segmentation
Market Insight, by Technology
· Hardware
· Software Solutions
· Services
Market Insight, by Application
· Cardiac Arrhythmias
· Stroke
· Cardiac Heart Disease
· Others
Market Insight, by Region
· North America
o U.S.
o Canada
o Rest of North America
· Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
· APAC
o China
o Japan
o India
o Rest of APAC
· Rest of the World
Top Company Profiles
· IDOVEN
· CardiAI
· Ultromics Limited
· Arterys Inc
· Cardiologs
· UltraSight
· DiA Imaging Analysis
· HeartVista Inc
· Viz.ai, Inc.
· RSIP Vision
Get a call back
